Literature DB >> 30809808

microRNA-211 promotes invasion and migration of colorectal cancer cells by targeting FABP4 via PPARγ.

Dongmei Zhao1, Yanying Ma1, Xu Li1, Xiaoyu Lu1.   

Abstract

Fatty acid binding protein 4 (FABP4) is a novel tumor regulator that is abnormally expressed in many human cancers. In our study, upregulated microRNA-211 (miR-211) and reduced FABP4 expression were detected in colorectal cancer (CRC) patients and CRC cells. Mimic miR-211 or anti-miR-211 were transfected to investigate the effects of miR-211 on SW480 cells. The results showed that miR-211 promoted but anti-miR-211 inhibited cell migration, invasion, and epithelial-mesenchymal transition (EMT) of SW480 cells. Luciferase activity was decreased after cotransfection with miR-211 and WT-FABP4-UTR in SW480 cells. And reduced FABP4 protein expression by miR-211 indicated that FABP4 was the targeted gene of miR-211. miR-211 inhibited the activation of peroxisome proliferator-activated receptor (PPAR) γ, whereas overexpression of FABP4 reversed that effect. Finally, FABP4 inhibited the migration, invasion, and EMT of SW480 cells, whereas PPARγ agonist reversed the effects of FABP4. Thus, the miR-211/FABP4/PPARγ axis may be a novel target for CRC therapy.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  epithelial-mesenchymal transition; fatty acid binding protein 4; microRNA-211; peroxisome proliferator-activated receptor γ

Year:  2019        PMID: 30809808     DOI: 10.1002/jcp.28190

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  10 in total

1.  25-HC promotes hepatocellular carcinoma metastasis through up-regulation of TLR4 dependent FABP4.

Authors:  Saisai Wang; Yuanyuan Yao; Xiao Wang; Gang Zheng; Wei Ouyang; Wenbin Chen
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

2.  Tumor Microenvironment Heterogeneity-Based Score System Predicts Clinical Prognosis and Response to Immune Checkpoint Blockade in Multiple Colorectal Cancer Cohorts.

Authors:  Hufei Wang; Zhi Li; Suwen Ou; Yanni Song; Kangjia Luo; Zilong Guan; Lei Zhao; Rui Huang; Shan Yu
Journal:  Front Mol Biosci       Date:  2022-06-28

3.  Evaluation of the Diagnostic Potential of a Plasma Exosomal miRNAs Panel for Gastric Cancer.

Authors:  Jiajia Yang; Xuan Li; Shuchun Wei; Lei Peng; Huaiming Sang; Duochen Jin; Meihong Chen; Yini Dang; Guoxin Zhang
Journal:  Front Oncol       Date:  2021-08-04       Impact factor: 6.244

4.  Molecular docking and machine learning analysis of Abemaciclib in colon cancer.

Authors:  Jose Liñares-Blanco; Cristian R Munteanu; Alejandro Pazos; Carlos Fernandez-Lozano
Journal:  BMC Mol Cell Biol       Date:  2020-07-08

5.  microRNA-211 regulates cell proliferation, apoptosis and migration/invasion in human osteosarcoma via targeting EZRIN.

Authors:  Yihua Pei; Qin Yao; Yingchao Li; Xin Zhang; Bozhen Xie
Journal:  Cell Mol Biol Lett       Date:  2019-07-09       Impact factor: 5.787

6.  Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.

Authors:  Mengwei Wu; Hongwei Yuan; Xiaobin Li; Quan Liao; Ziwen Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-15       Impact factor: 5.555

Review 7.  Therapeutic Implications of FABP4 in Cancer: An Emerging Target to Tackle Cancer.

Authors:  Naihui Sun; Xing Zhao
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

8.  Identification of tumor microenvironment-related prognostic genes in colorectal cancer based on bioinformatic methods.

Authors:  Yi Liu; Long Cheng; Chao Li; Chen Zhang; Lei Wang; Jiantao Zhang
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

9.  Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer.

Authors:  Kang Lin; Jun Huang; Hongliang Luo; Chen Luo; Xiaojian Zhu; Fanqin Bu; Han Xiao; Li Xiao; Zhengming Zhu
Journal:  Aging (Albany NY)       Date:  2020-03-31       Impact factor: 5.682

10.  High expression of FABP4 and FABP6 in patients with colorectal cancer.

Authors:  Yaqin Zhang; Xiaotong Zhao; Lili Deng; Xueting Li; Ganbiao Wang; Yongxing Li; Mingwei Chen
Journal:  World J Surg Oncol       Date:  2019-10-24       Impact factor: 2.754

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.